60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

7 trials found

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00455312 (ClinicalTrials.gov)	August 2007	30/3/2007	Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA	Hematopoietic Stem Cell Transplant For Patients With Dyskeratosis Congenita and Severe Aplastic Anem ...	Dyskeratosis Congenita;Aplastic Anemia	Drug: Campath 1H;Drug: Cyclophosphamide;Drug: Fludarabine;Procedure: Total Body Irradiation;Procedure ...	Masonic Cancer Center, University of Minnesota	NULL	Completed	N/A	70 Years	All	36	Phase 2/Phase 3	United States
2	NCT00195624 (ClinicalTrials.gov)	September 15, 2005	16/9/2005	Alemtuzumab to Treat Severe Aplastic Anemia	A Pilot Study of Alemtuzumab (Campath) in Patients With Relapsed or Refractory Severe Aplastic Anemi ...	Severe Aplastic Anemia, Refractory;Severe Aplastic Anemia, Relapse	Biological: Alemtuzumab (Campath );Drug: Cyclosporine	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	2 Years	110 Years	All	47	Phase 2	United States
3	NCT00065260 (ClinicalTrials.gov)	July 2003	18/7/2003	Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia	A Randomized Trial of Immunosuppression in Aplastic Anemia Patients With Refractory Pancytopenia or ...	Aplastic Anemia	Drug: Campath -1H;Drug: r-ATG;Drug: CsA	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	2 Years	N/A	All	54	Phase 2	United States
4	NCT00533923 (ClinicalTrials.gov)	December 2002	20/9/2007	Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treat ...	Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treat ...	AML;ALL;CLL;Myelodysplastic Syndrome;Non-Hodgkin's Lymphoma;Hodgkin's Lymphoma;Multiple Myeloma;Apla ...	Drug: Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF	Beth Israel Deaconess Medical Center	Bayer	Completed	N/A	65 Years	Both	25	Phase 2	United States
5	NCT00578903 (ClinicalTrials.gov)	February 2002	19/12/2007	Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia	Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia, Using Matched Unrelat ...	Aplastic Anemia	Drug: Cytoxan;Drug: Campath;Radiation: Total Body Irradiation (TBI);Drug: FK-506;Drug: Methotrexate; ...	Baylor College of Medicine	The Methodist Hospital System;Texas Children's Hospital;Center for Cell and Gene Therapy, Baylor Col ...	Terminated	N/A	60 Years	All	22	Phase 2	United States
6	NCT00590460 (ClinicalTrials.gov)	July 2001	26/12/2007	Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fancon ...	Cd45 (Yth-24 and Yth 54) and Cd52 (Campath-1H) Monoclonal Antibody Conditioning Regimen for Allogene ...	Fanconi Anemia;Severe Aplastic Anemia	Biological: CAMPATH -1H;Biological: Anti-CD45;Drug: Fludarabine;Procedure: Stem cell infusion	Baylor College of Medicine	The Methodist Hospital System;Center for Cell and Gene Therapy, Baylor College of Medicine	Terminated	N/A	N/A	All	5	Phase 1/Phase 2	United States
7	NCT00004143 (ClinicalTrials.gov)	September 1999	10/12/1999	Allogeneic Mixed Chimerism Stem Cell Transplant Using Campathfor Hemoglobinopathies & Bone Marrow Fa ...	Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campathfor Hemog ...	Sickle Cell Anemia;Severe Aplastic Anemia;Paroxysmal Nocturnal Hemoglobinuria (PNH);Pure Red Cell Ap ...	Drug: Campath , Chemo and/or TBI Allo SCT	David Rizzieri, MD	NULL	Completed	18 Years	N/A	All	2	Phase 2	United States

First Previous1Next Last